Magazine | Pharma Business International

Vol 6 - Iss 4

Vol 6 - Iss 5

Vol 6 - Iss 6

Vol 6 - Iss 1

Vol 6 - Iss 2

Vol 6 - Iss 3

Vol 5 - iss 4

Vol 5 - iss 5

Vol 5 - iss 6

Vol 5 - Iss 1

Vol 5 - Iss 2

Vol 5 - Iss 3

EDITOR PICKS

Axovant in-licences gene therapies from UMass

Axovant in-licences gene therapies from UMass

17th December 2018

European approval for self-administration of Novartis’ Xolair

European approval for self-administration of Novartis’ Xolair

14th December 2018

Bausch Health acquiring beleaguered Synergy out of bankruptcy

Bausch Health acquiring beleaguered Synergy out of bankruptcy

14th December 2018

POPULAR POSTS

PredictImmune secures £100k to advance biomarker-based tech

Atlantis initiatives rolling submission for pouchitis treatment NDA

3rd May 2017

Sanofi gains CHMP recommendation for Insulin lispro biosimilar

Servier, CTI BioPharma expand agreement to develop, commercialise Pixuvri

28th April 2017

Promising ALS therapy impresses in clinical trials

US approves first ALS drug in two decades

8th May 2017